Litigation Details for E.I. DuPont de Nemours and Company v. Unifrax I LLC (D. Del. 2014)
✉ Email this page to a colleague
E.I. DuPont de Nemours and Company v. Unifrax I LLC (D. Del. 2014)
Docket | ⤷ Try a Trial | Date Filed | 2014-10-01 |
Court | District Court, D. Delaware | Date Terminated | 2017-09-19 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | Both | Referred To | |
Patents | 10,029,011; 8,008,032; 8,044,014; 8,048,035; 9,056,052 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in E.I. DuPont de Nemours and Company v. Unifrax I LLC
Biologic Drugs cited in E.I. DuPont de Nemours and Company v. Unifrax I LLC
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for E.I. DuPont de Nemours and Company v. Unifrax I LLC (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-05-01 | 281 | Transcript | Right, right. I forgot to say, you know, 10:29:11 10 other than possibly Tuesday, you …having a patent relating to it, but not the patent at issue, 13 but a parent patent, the…some 09:15:15 25 predecessor patents, parent patents. Case 1:14-cv-01250-RGA Document…HOLDREITH: He was the patent prosecutor on 7 DuPont's patents. He would be relevant… 24 of the layers that's in the patent. One of the three layers is 08:41:53 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |